Morgan Stanley’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $620K | Buy |
202,038
+67,128
| +50% | +$206K | ﹤0.01% | 5362 |
|
|
2025
Q1 | $260K | Sell |
134,910
-65,684
| -33% | -$127K | ﹤0.01% | 5627 |
|
|
2024
Q4 | $750K | Buy |
200,594
+80,800
| +67% | +$302K | ﹤0.01% | 5234 |
|
|
2024
Q3 | $586K | Buy |
119,794
+511
| +0.4% | +$2.5K | ﹤0.01% | 5323 |
|
|
2024
Q2 | $895K | Buy |
119,283
+79,352
| +199% | +$595K | ﹤0.01% | 5027 |
|
|
2024
Q1 | $992K | Buy |
+39,931
| New | +$992K | ﹤0.01% | 4958 |
|